Biomedical Science

Biomedical Science

Breast cancer – early detection

Photoacoustic imaging is an effective tool for diagnostic imaging for the early detection of breast cancer. This technology uses optical as well as acoustic effects. Thus, this method provides a good combination of diagnostic accuracy and spatial resolution in imaging. Therefore, photoacoustic imaging is perfectly suitable as an alternative for mammography – and it completely avoids harmful radiation exposure for the patients.


Operation accompanying imaging without X-ray exposure

In some situations it is helpful for the operating surgeon to use the support of a continuous imaging system (e.g. during a brain operation). In order to keep the X-ray radiation exposure as low as possible for the patients and the medical staff, Photoacoustic imaging photoacoustic imaging (another research area of RECENDT) can be applied.

Point-of-Care – Diagnostics for blood and urine

Spectroscopic methods provide highly efficient analysis of blood and urine samples. These methods allow a quick determination of various clinical parameters under Point-of-Care (POC) conditions. With such modern technologies time-consuming laboratory analysis are not necessary, and in addition, minimal amounts of liquid can be reliably measured. Thus, such approaches can be applied to intensive care and paediatrics / neonatology, or on-site use for emergency doctors.

Point-of-Care – Diagnostic of malign changes of skin (in-vivo)

Modern technologies are able to provide an immediate assessment of suspicious changes in skin – ideally by combining several methods: for example, contactless Infrared or Raman Spectroscopy can create spectral/chemical fingerprints of skin changes, and the Optical Coherence Tomography (OCT) is able to show microstructural skin changes.

Spatially resolved spectroscopy

Do you want to know the exact local distribution (in micrometer range) of your chemical components? With Mid-Infrared-Microscopy we can chemically characterize and measure materials and cross-sections (e.g. residues or inclusions) with a spatial resolution as small as 5 µm.

Nano-Medicine & Pharmaceutical Development

We are unable to develop the API - this might be your expertise! But when it comes to carrier development and process upscaling, you can rely on our experience of the application of process for analytical technologies (e.g. spectroscopic techniques) to serve as a support unit for precision medicine / nano medicine / personalized medicine and pharmaceutical development in general.